Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
| 2024-01-04 Sale | 2024-01-05 4:14 pm | Apellis Pharmaceuticals Inc. | APLS | Baumal Caroline Chief Medical Officer | 2,751 | $60.05 | $165,207 | 32,931 (Direct) | View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
| 2024-01-16 Option Award | 2024-01-17 4:33 pm | N/A N/A | Apellis Pharmaceuticals Inc. | APLS | Baumal Caroline Chief Medical Officer | 25,445 | $0 | 95,376 (Direct) | View |
| 2024-01-16 Option Award | 2024-01-17 4:33 pm | N/A 2034-01-15 | Apellis Pharmaceuticals Inc. | APLS | Baumal Caroline Chief Medical Officer | 37,000 | $66.3 | 95,376 (Direct) | View |
Ownership | 2023-01-09 4:44 pm | N/A N/A | Apellis Pharmaceuticals Inc. | APLS | Baumal Caroline Chief Medical Officer | 0 | $0 | 133 (Direct) | View |
| 2023-01-03 Option Award | 2023-01-05 7:57 pm | N/A N/A | Apellis Pharmaceuticals Inc. | APLS | Baumal Caroline Chief Medical Officer | 35,549 | $0 | 84,682 (Direct) | View |
| 2023-01-03 Option Award | 2023-01-05 7:57 pm | N/A 2033-01-02 | Apellis Pharmaceuticals Inc. | APLS | Baumal Caroline Chief Medical Officer | 49,000 | $50.28 | 84,682 (Direct) | View |
Ownership | 2023-01-05 7:48 pm | N/A N/A | Apellis Pharmaceuticals Inc. | APLS | Baumal Caroline Chief Medical Officer | 0 | $0 | 133 (Direct) | View |